Publications by authors named "Andrew Hsieh"

Claim this Profile
E
Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease.
Michael H Davidson, Michael Szarek, Philip Scheltens, Everard Vijverberg, Andrew Hsieh

J Prev Alzheimers Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial.
Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, Kelsey K Baker, Kevin Ng, Andrew C Hsieh

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study.
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, Leonidas Ν Diamantopoulos, Dimitrios Makrakis, Andrew C Hsieh

Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of unmet clinical needs and healthcare resource use among statin-treated patients with or at risk of developing atherosclerotic cardiovascular disease.
Nancy Ortiz, Jacqueline Shehata, Jeremy Smart, Brian Leinwand, Ahan Ali, Andrew Hsieh

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N6-methyladenosine regulation of mRNA translation is essential for early human erythropoiesis.
Daniel A Kuppers, Sonali Arora, Cindy L Wladyka, Ruiqi Ge, Shun Liu, Andrew C Hsieh

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis.
Stephen J Nicholls, Adam J Nelson, Kausik K Ray, Christie M Ballantyne, Marc Ditmarsch, Andrew Hsieh

J Am Coll Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cysteine Reactivity Profiling Illuminates Monoclonal Antibody Disulfide Bond Reduction Mechanisms in Biopharmaceutical Process Intermediates.
Taku Tsukidate, Zhenshu Wang, Andrew Hsieh, Patricia Rose, Xuanwen Li

J Am Soc Mass Spectrom· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Drug-Drug Interaction Study Evaluating the Pharmacokinetic Consequences of Obicetrapib Therapy on Atorvastatin or Rosuvastatin Levels in Healthy Volunteers.
John J P Kastelein, Marc Ditmarsch, Andrew Hsieh, Douglas Kling, Ashley Walker

Am J Cardiovasc Drugs· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotyping.
Dana Cavanaugh, Sarah K Holt, Erin Dwyer, Erin Petersen, John L Gore, Andrew C Hsieh

Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.
Hyun Jung Lee, Roman Gulati, Erolcan Sayar, Radhika A Patel, Pushpa Itagi, Andrew C Hsieh

Cancer Res Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, John J P Kastelein, Christie M Ballantyne, Andrew Hsieh

N Engl J Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding post-transcriptional regulatory networks by RNA-linked CRISPR screening in human cells.
Patrick J Nugent, Heungwon Park, Cynthia L Wladyka, James N Yelland, Sayantani Sinha, Andrew C Hsieh

Nat Methods· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity.
Stephanie Dobersch, Naomi Yamamoto, Aidan Schutter, Sarah M Cavender, Tess M Robertson, Andrew C Hsieh

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raman spectroscopy for monitoring free sulfhydryl formation during monoclonal antibody manufacturing.
Zhenshu Wang, Andrew Hsieh, Patricia Rose, George Zhou, Sonja Battle

J Pharm Biomed Anal· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study.
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, Sarah K Holt, Rishi R Sekar, Andrew C Hsieh

Clin Genitourin Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials.
Stephen J Nicholls, Adam J Nelson, John J P Kastelein, Marc Ditmarsch, Andrew Hsieh

Pharmacol Res Perspect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity.
Michael H Davidson, Andrew Hsieh, John J P Kastelein

Curr Opin Lipidol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.
Shankha S Chatterjee, Juan F Linares, Tania Cid-Diaz, Angeles Duran, Mohd Imran K Khan, Andrew C Hsieh

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Ionic Liquids on the Nucleofugality of Dimethyl Sulfide.
Andrew Y Hsieh, Ronald S Haines, Jason B Harper

J Org Chem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN.
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, John J P Kastelein, Christie M Ballantyne, Andrew Hsieh

Am Heart J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Parallel, Open-Label, Single-Dose and Multiple-Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China.
Jing Zhang, Guoying Cao, Yong Huo, Liana L Guarneri, Marc Ditmarsch, Andrew Hsieh

J Clin Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development.
Michael H Davidson, Andrew Hsieh, Mary R Dicklin, Kevin C Maki

JACC Basic Transl Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding RNA Metabolism by RNA-linked CRISPR Screening in Human Cells.
Patrick J Nugent, Heungwon Park, Cynthia L Wladyka, Katharine Y Chen, Christine Bynum, Andrew C Hsieh

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer.
Elizabeth L Koehne, Dimitra R Bakaloudi, Fady Ghali, Yaw Nyame, George R Schade, Andrew C Hsieh

Clin Genitourin Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older.
Fady Ghali, Sarah K Holt, Elizabeth L Koehne, Jonathan J Chen, Emily S Weg, Andrew C Hsieh

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis